Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Givastomig, an antibody targeting Claudin 18.2 × 4-1BB.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Etakafusp, an antibody targeting CD8.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Izastobart, an antibody targeting C5AR1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Calotatug, an antibody targeting HER2.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ebrasodebart, an antibody targeting TMEM219.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Emiltatug, an antibody targeting VTCN1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Aplitabart, an antibody targeting TNFRSF10B.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Budoprutug, an antibody targeting CD19.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Cabotamig, an antibody targeting CDH17 × CD3E.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Aldastotug, an antibody targeting SIGLEC15.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ansipastobart, an antibody targeting CD73.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Torvutatug, an antibody targeting Folate receptor alpha.